Boston biopharma Karuna Therapeutics appointed Bill Meury as its new president and chief executive officer, succeeding its current head, Steve Paul, the company announced Tuesday. Meury starts on Jan. 3, 2023.
https://www.pharmalive.com/wp-content/uploads/2022/12/BioSpaceexecutives12-6-2022.jpg350625BioSpacehttps://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.pngBioSpace2022-12-07 10:33:372022-12-07 10:33:37Karuna taps new CEO, prepares to submit NDA for schizophrenia candidate
